Elsevier

Biochemical Pharmacology

Volume 62, Issue 11, December 2001, Pages 1511-1519
Biochemical Pharmacology

Expression of rat aldehyde reductase AKR7A1: influence of age and sex and tissue-specific inducibility, 1

https://doi.org/10.1016/S0006-2952(01)00771-7Get rights and content

Abstract

The regulation of the aldo-keto reductase AKR7A1 was examined in the livers of male and female rats during development by using Western blots, and its contribution to carbonyl metabolism was assessed by using enzyme assays. Hepatic levels of AKR7A1 are low in fetal rats and rise to a peak at around 6 weeks of age in animals of both sexes. Higher levels of the enzyme are found in adult male rat liver than in adult female rat liver. The reductase, therefore, appears to be subject to sex-specific regulation. The effect of growth hormone in mediating this difference in expression was examined by using hypophysectomized animals whose serum growth hormone levels had been feminized by continuous administration. Results demonstrate that such treatment leads to a reduction in AKR7A1 expression. AKR7A1 was found to be constitutively expressed in rat tissues such as liver, kidney, small intestine, and testis, but it was not detected in nasal mucosa, skeletal muscle, heart, adrenal gland, brain, or spleen. However, AKR7A1 was inducible by the synthetic antioxidant ethoxyquin in liver, kidney, and small intestine, but not in the other tissues examined. These results show that levels of this important detoxication enzyme vary considerably according to age and sex and that dietary antioxidants can also influence its level in several tissues.

Introduction

Aldehydes and ketones are ubiquitous in the environment, and some of these compounds have been shown to cause damage to protein, DNA, and membranes, leading to toxicity and mutagenicity [1]. Most organisms have evolved protective mechanisms to detoxify carbonyl-containing compounds. Enzymatic defences include the glutathione S-transferases, which can conjugate glutathione (GSH) to reactive carbonyls [2]; aldehyde dehydrogenases, which can oxidize aldehydes to acids [3]; and enzymes, which can reduce aldehydes and ketones to alcohols [4]. This latter biotransformation is catalysed by enzymes that fall into three separate families: the aldo-keto reductases [4]; the alcohol dehydrogenases, and NAD(P)H:quinone oxidoreductase (NQO1; also called DT-diaphorase). The aldo-keto reductases comprise a large superfamily of NAD(P)H-dependent reductases, members of which have been isolated from a variety of species and tissues [5], [6]. Several members of this family have been identified in the rat, including aldehyde reductase (AKR1A3) [7], aldose reductase (AKR1B4) [8], and 3α-hydroxysteroid dehydrogenase (AKR1C9) [9], [10]. In addition to their potential roles in detoxification, aldo-keto reductases can reduce sugars, steroids, and prostaglandins, but because of their overlapping substrate specificity, definitive functions have been difficult to ascribe.

We have previously identified and characterized an aldehyde reductase from rat liver (AKR7A1) that is capable of detoxifying a dialdehyde metabolite of aflatoxin B1[11], [12]. This enzyme is also capable of reducing a range of cytotoxic and mutagenic aldehydes and ketones, including products of lipid peroxidation such as 4-hydroxynonenal and hexanal [13]. We have shown that the hepatic level of this enzyme, unlike most other members of the aldo-keto reductase family, is increased in rats after dietary exposure to certain xenobiotics. Such inducing agents include the phenolic antioxidants butylated hydroxyanisole and ethoxyquin, as well as naturally occurring compounds including coumarin [12], [14]. Levels of AKR7A1 are also elevated in the liver of rats raised on a selenium-deficient diet [15]. Modulation of the level of AKR7A1 correlates with profound differences in susceptibility to chemical carcinogenesis: animals with high levels of AKR7A1 in the liver appear to be more resistant to the hepatocarcinogen aflatoxin B1 than are animals with low levels of AKR7A1 [11].

This study was designed to investigate whether factors such as age and sex also influence the expression of AKR7A1, as well as to examine the tissue-specific inducibility of this enzyme. Such information can provide insights into factors that may affect susceptibility to the effects of toxic aldehydes and ketones, as well suggesting additional biological roles for this important enzyme in normal cellular processes.

Section snippets

Animals

Developmental expression of AKR7A1 was examined in male and female Fischer 344 rats that were purchased from Harlan Olac Ltd. (Oxon, England). Such animals were fed ad lib a control diet comprising RM1 diet (SDS Ltd., Edinburgh, Scotland) [15]. Livers were prepared from fetal animals (17 days gestation) or animals at the ages of 2, 4, 6, 8, 10, and 12 weeks. Tissue-specific expression was examined in the same animals. For the enzyme induction experiments, 10-week-old animals were fed on a RM1

Ontogenic regulation of AKR1A7 expression in the liver

Previous studies have shown that, whereas some carbonyl-reducing enzymes are expressed in the livers of adult rats, others, such as aldose reductase (AKR1B4), are only expressed in fetal liver [21]. These levels may influence sensitivity to toxic aldehydes and ketones. To investigate whether there is any variation in the expression of AKR7A1 during development, liver extracts prepared from male and female Fischer 344 rats of different ages were examined by using western blots probed with a

Discussion

The important role played by AKR7A1 in the metabolism of aflatoxin B1 metabolites has been clearly demonstrated [11], [24], [26]. Its regulation by dietary constituents has been shown to contribute to the detoxication of the hepatocarcinogen in exposed animals [11], [27]. In the present study, we have shown that AKR7A1 is also regulated by other factors, including age and sex, and that is inducible in the small intestine.

Age-specific regulation of hepatic enzymes including other

Acknowledgments

We thank Professor Iain Hunter for use of the Beckman spectrophotometer and Dr. Derek Jamieson for helpful comments.

References (43)

  • W.F Bosron et al.

    Alcohol dehydrogenase

  • B Wermuth

    Aldo-keto reductases

  • AKR Homepage. http://www.med.upenn.edu/akr. Accessed 15th October,...
  • M Takahashi et al.

    Identity of a major 3-deoxyglucosone-reducing enzyme with aldehyde reductase in rat liver established by amino acid sequencing and cDNA expression

    Gene

    (1993)
  • T Penning et al.

    Purification and properties of a 3a-hydroxysteroid dehydrogenase of rat liver cytosol and its inhibition by anti-inflammatory drugs

    Biochem J

    (1984)
  • J.D Hayes et al.

    Resistance to aflatoxin-B1 is associated with the expression of a novel aldo-keto reductase which has catalytic activity towards a cytotoxic aldehyde-containing metabolite of the toxin

    Cancer Res

    (1993)
  • E.M Ellis et al.

    An ethoxyquin-inducible aldehyde reductase from rat liver that metabolizes aflatoxin B1 defines a subfamily of aldo-keto reductases

    Proc Natl Acad Sci USA

    (1993)
  • E.M Ellis et al.

    Substrate specificity of an aflatoxin-metabolizing aldehyde reductase

    Biochem J

    (1995)
  • V.P Kelly et al.

    Chemoprevention of aflatoxin B1 hepatocarcinogenesis by coumarin, a natural benzopyrone that is a potent inducer of AFB1-aldehyde reductase, the glutathione S-transferase A5 and P1 subunits, and NAD(P)H:quinone oxidoreductase in rat liver

    Cancer Res

    (2000)
  • R McLeod et al.

    Protection conferred by selenium deficiency against aflatoxin B1 in the rat is associated with the hepatic expression of an aldo-keto reductase and a glutathione S-transferase subunit that metabolize the mycotoxin

    Cancer Res

    (1997)
  • L Staffas et al.

    Growth hormone- and testosterone-dependent regulation of glutathione transferase subunit A5 in rat liver

    Biochem J

    (1998)
  • Cited by (11)

    • Aldo-keto reductases 7A subfamily: A mini review

      2024, Chemico-Biological Interactions
    • Simultaneous measurement of urinary polyols using gas chromatography/mass spectrometry

      2006, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
    • Substrate specificity of mouse aldo-keto reductase AKR7A5

      2003, Chemico-Biological Interactions
      Citation Excerpt :

      Recently, the crystallisation of the rat AKR7A1 enzyme has revealed details of its dimeric structure [5]. The rat AKR7A1 enzyme is expressed in liver, kidney, testis, small intestine and pancreas [6,7]. However, a unique feature of this enzyme is its inducibility by a range of dietary components and synthetic antioxidants, including ethoxyquin and coumarin [2,6,8,9].

    View all citing articles on Scopus

    This work was funded partly by a grant from the Association for International Cancer Research. EME was supported by a Beit Memorial Fellowship and VPK was supported by a Biomedical Research Centre Studentship. The experiments performed in Stockholm were supported by the Knut and Alice Wallenberg Foundation.

    1

    Abbreviations: 2-CBA, 2-carboxybenzaldehyde; 4-NBA, 4-nitrobenzaldehyde; 9,10-PQ, 9,10-phenanthrenequinone; NQO1, NAD(P)H:quinone oxidoreductase; GH, growth hormone; GSH, glutathione; and SDS, sodium dodecyl sulfate.

    View full text